We first investigated SASP expression in our GEMM lung tumors and found that expression of the SASP is significantly impaired in Tlr2-null tumors (with and without active Trp53), suggesting that SASP expression may explain the Trp53 independent tumor suppressor effects of Tlr2. The gene discussed is TP53; the disease is neoplasm.